Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
7,012
NCT00066898
ARISE - Aggressive Reduction of Inflammation Stops Events
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2003
Completion: Dec 31, 2006
NCT00525577
ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study
Phase: Phase 2/3
Start: Aug 31, 2007
Completion: Sep 30, 2008